Optimal medical therapy with or without PCI for stable coronary disease.

By William E Boden, Robert A. O’Rourke, Koon K. Teo, P. Hartigan, D. Maron, William J. Kostuk, M. Knudtson, Marcin Dada, P. Casperson, C. Harris and 13 more. New England Journal of Medicine, 2007

4,308 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/35a28a39e1f7cc414c738eed112ad698ccff2426

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Douglas G. Altman
2. David Moher
3. P. Gøtzsche
4. Michael J. Pencina
5. Rick A. Nishimura
6. J. Halperin
7. K. F. Schulz
8. James K. Min

In Surgery

1. David Moher
2. Douglas G. Altman
3. Michael J. Pencina
4. James K. Min
5. F. Cosentino
6. Joshua A. Beckman
7. Judith Hochman
8. Matthias Egger

Citations in the corpus

• Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. (2013, methodology): “comes of optimal medical therapy (OMT) with and without percutaneous coronary intervention (PCI).(152) Over a median 4.”
• CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. (2012, result): “…factor may be perceived as a limitation, published data indicate no benefit (either short-term or long-term) with respect to death and myocardial infarction in patients with stable coronary artery disease who receive drug-eluting stents, as compared with those who receive bare-metal stents’’[253].”
• Guidelines on myocardial revascularization. (2010, methodology): “Evaluation prior to hospital discharge I B [36,41 43]”